The role of prostaglandins in maintenance of resting cerebral blood flow (CBF) and in cerebral vaso dilatation during hypercapnia remains controversial. The effect of indomethacin, a cyclo-oxygenase inhibitor, on CBF and cerebrovascular resistance (CVR) was exam ined in conscious animals. Regional and total CBF were measured with radioactive microspheres, and the efficacy of blockade of prostaglandin synthesis by indomethacin was examined by the cranial window method. CBF was measured in conscious rabbits with 15-lLm radioactive mi crospheres during normocapnia (Peo2 = 30 mm Hg) and hypercapnia (Peo2 = 60 mm Hg), before and after intra venous administration of indomethacin (10 mg/kg) or ve hicle (n = 6 for each). Thus, each animal served as its own control. CBF was 84 ± 6 and 190 ± 27 (mean ± SE) mllmin/lOO g during normocapnia and hypercapnia, respectively, before indomethacin, and 78 ± 5 mllmin/l00 g during normocapnia and 180 ± 16 mllmin/lOO g during hypercapnia following indomethacin. Thus, indomethacin Although prostaglandins are synthesized by ce rebral vessels and brain parenchyma (Wolfe et al., 1976; Abdel-Halim et al., 1980; Goehlert et aI., 1981) and exert vasoactive effects (Ellis et aI., 1979), their role in regulation of cerebral blood flow (CBF) is unclear. The role of prostaglandins in the control of CBF has been examined primarily by the use of cyclo-oxygenase inhibitors such as indomethacin. Several investigators have found that indomethacin decreases CBF during normocapnia by 30-50% and virtually eliminates the increase in CBF during hy percapnia in anesthetized monkeys, rats, gerbils, and conscious rats (Pickard and Mackenzie, 1973; Sakabe and Siesj6, 1979; Dahlgren et al., 1981a,b; 
did not change normocapnic CBF. In addition, cerebro vascular responses during hypercapnia did not vary be tween the indomethacin and vehicle groups. Indometh acin did not attenuate increases in blood flow in any area of the brain, except slightly to cerebellum during hyper capnia. Indomethacin did not affect CVR during normo capnia or hypercapnia. The topical application of arachi donic acid (75 and 150 lLg/mg), dissolved in cerebrospinal fluid, dilated pial arteries in a dose-dependent fashion. Intravenous administration of indomethacin (10 mg/kg) blocked vasodilatation produced by arachidonic acid by 87% (p < 0.05). Thus, indomethacin, at a dose that ef fectively inhibits prostaglandin synthesis, did not change resting CBF or CVR or attenuate the increase in CBF or decrease in CVR during hypercapnia. These findings sug gest that prostaglandins do not contribute significantly to regulation of the cerebral circulation during normocapnia and hypercapnia. Key Words: Cerebral blood flow-Cer ebrovascular resistance-Indomethacin-Microspheres. Crockard et aI., 1982; McCulloch et aI., 1982) without affecting cerebral metabolism (McCulloch et al., 1982) . In contrast, Busija and Heistad (1983) , Cuypers et al. (1978) , and Wei et al. (1980) found that indomethacin had little or no effect on CBF or pial artery diameter during normocapnia or hyper capnia in anesthetized cats or rabbits. Diff erences in results may be due to nonspecific depressant effects on the cerebral circulation resulting from prepara tion and/or mode of delivery of indomethacin in the other studies (Wei et al., 1980; Busija and Heistad, 1983) . However, recently it has been suggested that use of anesthesia in the latter studies may have de pressed cerebrovascular reactivity to carbon dioxide and led to contradictory results (Pickard, 1981) .
In these experiments, the effects of indomethacin on CBF during two levels of arterial PC02 have been examined in conscious animals. Important ap proaches used were that, first, CBF was measured with radiolabeled microspheres. This allowed mul tiple measurements of regional, as well as total CBP, so that each animal could serve as its own control. Second, the efficacy of blockade of pros taglandin synthesis by indomethacin was examined with the cranial window method.
MATERIALS AND METHODS
These experiments were designed to examine effects of indomethacin on CBF. Twelve rabbits (3.3-4.3 kg) were lightly anesthetized with sodium pentothal (50 mg/kg) ad ministered through an ear vein. Following local injection of lidocaine, a catheter (PE-90) was inserted into the left ventricle (via right femoral artery) for microsphere injec tion; into the left femoral artery for blood pressure re cording, blood sampling, and withdrawal of reference blood samples; and into the left femoral vein for infusion of drugs. The animal was studied 4-5 h after regaining consciousness. The rabbit was placed into a restraint de vice, and another catheter was inserted into an ear artery for withdrawal of a second reference blood sample. The femoral artery catheter was connected to an injection cap (Becton-Dickinson, Rutherford, NJ, U.S.A.). By in serting two needles into an injection cap, arterial blood pressure could be accurately monitored during simulta neous withdrawal of a reference blood sample (0.51 mllmin).
The rabbit was placed into a plastic environmental chamber (22 x 30 x 45 cm). Heparin (500 Ulkg, i.v.) was administered for anticoagulation. Holes in the sides of the chamber allowed the introduction of various gas mixtures. Gases (�4 and �8% CO2 in air) were intro duced into the chamber at 4-6 Llmin to maintain arterial PC02 at either normocapnic or hypercapnic levels. CBF was measured with micro spheres (15 ± 3 /L m diameter, mean ± standard deviation; New England Nuclear, Boston, MA, U.S.A.) four times during each experiment: during normocapnia and after 12-15 min of hypercapnia, before and after intravenous administration of indometh acin trihydrate (10 mg/kg, water soluble; Merck Sharp & Dohme, Rahway, NJ, U.S.A.) dissolved in 20 ml saline, or only 20 ml saline (n = 6 for each group). This period of hypercapnia is sufficient for steady-state cerebrovas cular responses (unpublished observations). The use of microspheres in measuring blood flow has been described previously (Busija and Heistad, 1982) . From 150,000 to 850,000 micro spheres were injected each time. The mi crospheres were labeled with the following nuclides: 46SC, 85Sr, 113Sn, and 141Ce. The order of administration of la beled microspheres was randomized. The tip of the car diac catheter was in the left ventricle at the beginning and end of each experiment. Adequacy of mixing of micro spheres in the left ventricle was evaluated by comparing the number of micro spheres in the withdrawal samples from the femoral and ear arteries. The correlation coef ficient for the number of microspheres in the two samples was 0.97 (p < 0.05, n = 36 comparisons; in three animals, technical problems prevented sampling at two sites.). Thus, mixing of micro spheres in the left ventricle was very good.
Cranial window experiments
These experiments were designed to examine the effi cacy of inhibition of prostaglandin synthesis by indomethacin. Four rabbits were anesthetized initially with sodium pentothal (120 mg/kg) and then given ex-chloralose (40 mg/kg) to maintain anesthesia. Catheters were in serted into a femoral artery and vein and the animal was intubated and artificially ventilated. A burr hole was made in the skull over the cerebral hemispheres, and a cranial window was inserted into the opening and cemented in place. Artificial cerebrospinal fluid (CSF) was infused under the window. Pial artery diameter was measured with a Wild trinocular microscope (Heerbruss, F.R.G.) and a Vicker's image-shearing device (Woburn, ME, U.S.A.). Mter control measurements were obtained, CSF in the space under the window was replaced with CSF containing sodium arachidonate (either 75 or 150 /L g/ml; Nucheck, Inc., Elysian, MN, U.S.A.) before and after administration of indomethacin (10 mg/kg). The sodium arachidonate was prepared fresh each day immediately before use.
Statistical analysis
Arterial blood pressure, blood gases, CBF, and CVR during each condition (normocapnia and hypercapnia) were compared before and after vehicle or indomethacin by paired t tests. The ratios of changes in CBF or CVR responses before and after vehicle were compared with ratios of changes in CBF or CVR before and after indo methacin by unpaired t tests, following an arc-sine trans formation. Thus, differences in responsiveness to hyper capnia before and after drug infusion (vehicle or indo methacin) were compared between the two groups. Percent change in diameter of pial arteries from control, due to topical application of arachidonic acid before and after indomethacin, was compared by paired t tests (one tailed), following an arc-sine transformation. An ex-level of p < 0.05 was used in all statistical tests. Values are presented as means ± SE.
RESULTS

Efficacy of prostaglandin blockade by indomethacin
Topical application of arachidonic acid (75 and 150 J..L g/ml) increased pial artery diameter in a dose dependent manner (Pig. 1). Intravenous adminis tration of indomethacin effectively inhibited the dilatation for at least 40 min (87% inhibition for combined data, p < 0.05, n = 8). This period of inhibition was longer than the length of experiments following administration of indomethacin in the blood flow experiments. Thus, intravenous indo methacin was effective in blocking dilatation of pial arteries that was due to topical application of ara chidonic acid.
Effects of indomethacin on CBP and CVR
Administration of vehicle (Table 1) or 10 mg/kg indomethacin (Thble 2) had little or no effect on CBP during normocapnia. In both groups, CBP in creased by two-to threefold during hypercapnia, before and after administration of vehicle or indo methacin (Tables 1 and 2 ). The increase in CBP during hypercapnia tended to be less during the second exposure to hypercapnia (when arterial pressure was slightly lower), but was not signifi cant, except in cerebellum (Table 2 ). Responses to hypercapnia in the vehicle and indomethacin groups were not different from each other. CVR was not different during normocapnia or hy percapnia before and after administration of vehicle or indomethacin (Tables 1 and 2 , Fig. 2) . In both groups, CVR decreased during hypercapnia before and after vehicle and indomethacin, and there was no difference in responsiveness to hypercapnia be tween these groups.
DISCUSSION
The major finding of this study is that indometh acin, at a dose sufficient to inhibit prostaglandin synthesis effectively, has little or no effect on CBF or CVR during normocapnia and hypercapnia in conscious rabbits. Thus, it appears unlikely that prostaglandins are important in regulation of the ce rebral circulation under these conditions. Important features of these experiments are that conscious an imals were used, both total and regional CBF were measured, each animal served as its own control, and the efficacy of blockade of prostaglandin syn thesis by indomethacin was examined.
Two other laboratories have reported effects of indomethacin on the cerebral circulation in rabbits. Bill (1979) found that indomethacin (20 mg/kg) de creased CBF (measured with microspheres) during resting conditions in conscious rabbits. However, it is difficult to evaluate this study adequately because blood gas values were not reported, and control values for CBF were double those reported by others in conscious humans and animals. Cuypers et al. (1978) found that indomethacin did not attenuate the increase in white matter blood flow during hy percapnia in anesthetized rabbits. However, CBF was measured after only 2 min of hypercapnia, a period too short for steady-state cerebrovascular responses to be measured (Busija and Heistad, 1983) . In the present study, CBF was measured during normocapnia and after 12-15 min of hyper capnia.
Although numerous studies have reported that in domethacin affects CBF (Pickard and Mackenzie, 1973; Bill, 1979; Sakabe and Siesj6, 1979; Dahlgren et aI., 1981a,b; Crockard et aI., 1982; McCulloch et aI., 1982) , none of these studies have presented di rect evidence indicating that prostaglandin syn thesis in cerebral tissues or vessels was inhibited, and only two studies (Pickard and Mackenzie, 1973; Sakabe and Siesj6, 1979) have examined nonspe cific depressant effects on cerebral vessels. It had been suggested previously that results obtained by these studies may be due to nonspecific depressant effects on the cerebral circulation due to factors such as preparation and/or mode of delivery of indo methacin (Wei et ai., 1980; Busija and Heistad, 1983) . For example, Crockard et ai. (1982) found that imidazole, as well as indomethacin, prepared and delivered in the same fashion, blocked the in crease in CBF during hypercapnia, even though imidazole does not block prostaglandin synthesis normally. In addition, Wei et ai. (1980) found that prolonged infusion of a solution similar to the ve hicle used by Pickard and Mackenzie (1973) into cerebral arteries attenuated cerebrovascular dila tation during hypercapnia. It is possible that species differences may be involved, because a consistent finding has been that indomethacin affects CBF in rats. However, the cerebrovascular response to in domethacin in rats may not be related necessarily to inhibition of prostaglandin synthesis, but rather could be due to a direct nonspecific effect of indo methacin on cerebral vessels. In contrast, we (Busija and Heistad, 1983) and others (Wei et al., 1980) have demonstrated that indomethacin, at doses that ef fectively attenuate prostaglandin synthesis without having nonspecific depressant effects on cerebral vessels, does not affect CBF or pial artery diameter in anesthetized cats. We extended these earlier studies in two ways in the present study to include another species, the rabbit, as well as to examine effects of indomethacin on CBF and CVR in the unanesthetized state. Thus, it is unlikely that our previous results were due to an abnormal response in one species or to use of anesthesia.
Our results are consistent with findings from studies using cyclo-oxygenase inhibitors other than indomethacin. Wei et ai. (1980) found that AHR-5850 (sodium amfenac) did not affect pial artery diameter during normocapnia or hypercapnia. In addition, Pickard et al. (1977) and Amano and Meyer (1981) reported that aspirin did not aff ect CBF during hypercapnia in conscious humans.
So far, most of the evidence concerning the role of prostaglandins in regulation of CBF has been pharmacological. Recently, several laboratories have reported biochemical determinations of prostaglan dins in brain or cerebral venous blood during changes in arterial PC02 ' Ellis et al. (1982) found that pros taglandin E2 and F2rr levels in brain tissue actually decreased from normocapnia levels when cats were exposed to hypercapnia, while 6-keto-F 1rr did not change and pial arterial diameter increased 32%. In addition, in preliminary reports, McCalden et al. (1982) and Wennmalm et al. (1982) found that pros tacyclin levels in cerebral venous blood, in baboons and humans, respectively, did not increase from control levels during hypercapnia, whereas CBF in creased. Thus, biochemical determinations of pros taglandins during hypercapnia confirm pharmaco logical studies.
In summary, indomethacin, at a dose that effec tively attenuates synthesis of prostaglandins, does not alter CBF or CVR significantly at two levels of arterial PC02. Therefore, it seems unlikely that prostaglandins are involved in the regulation of ce rebral circulation under these conditions in con scious rabbits.
